sec filing
EK
NASDAQ · EKSO
Ekso Bionics Holdings, Inc.
Healthcare · Medical - Instruments & Supplies
$11.80
Down-$1.74 (-9.86%)
Updated Nov 4, 2026, 5:52 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 12.23M
- P/E ratio
- -1.17
- Dividend yield
- 0.00%
- 52-week range
- $2.73 – $13.50
- Volume
- 100.57K
- Avg. volume
- 140.03K
Price performance · EKSO
EKSO price history
1M range · 0 trading sessions · Daily adjusted prices
EKSO does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest EKSO news
The latest Smart Investors Daily articles mentioning EKSO.
Stock researchCompany · Overview
Company
Market Activity
Research & News
EKSO research
Overview
Company profile and research snapshot.
Company profile
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $6.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Dec 31, 2025 | HC Wainwright & Co. | Neutral | — |
| Nov 18, 2025 | HC Wainwright & Co. | Buy | — |
| Jul 29, 2025 | Lake Street | Buy | — |
| May 6, 2025 | HC Wainwright & Co. | Buy | — |
| Mar 4, 2025 | Lake Street | Buy | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.